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 9 
Interpretive summary  10 
 11 
There is now increasing evidence that diets in early life can influence health throughout later 12 
life. Milk and dairy foods are important sources of certain nutrients and have functional effects 13 
particularly important at certain life stages. This paper examines some of the key nutrition 14 
issues during childhood, adolescence, pregnancy, middle and older age and discusses where 15 
dairy foods can be helpful. As an example, these foods can aid bone development in childhood 16 
and adolescence, maintain adequate iodine status during pregnancy and reduce muscle loss by 17 
the elderly. 18 
 19 






Despite an ongoing increase in life expectancy, it is not always accompanied by an increase in 23 
healthy lifespan. There is increasing evidence that dietary exposure in early life can 24 
substantially impact on chronic disease risk in later life. Milk and dairy foods are important 25 
suppliers of a range of key nutrients with some being particularly important at certain life 26 
stages. It is now recognized that milk protein can stimulate insulin-like growth factor-1 (IGF-27 
1) essential for longitudinal bone growth and bone mass acquisition in young children, thus 28 
reducing the risk of stunting. Low milk consumption during adolescence, particularly by 29 
females, may contribute to sub-optimal intake of calcium, magnesium, iodine, and other 30 
important nutrients. Given the generally low vitamin D status of European populations, this 31 
may have already impacted bone development and any resulting reduced bone strength may 32 
become a big issue when they are much older. A sub-optimal iodine status of many young 33 
females has already been reported together with several observational studies showing an 34 
association between sub-optimal iodine status during pregnancy and reduced cognitive 35 
development by the offspring. There is now good evidence that consumption of milk/dairy 36 
foods does not lead to an increased risk of cardiovascular diseases and type 2 diabetes. Indeed 37 
some negative associations are seen, notably that between yogurt consumption and type 2 38 
diabetes, which should be researched with urgency. Greater emphasis should be placed on 39 
reducing malnutrition in the elderly and on dietary approaches to reduce their loss of muscle 40 
mass, its functionality and bone strength. Whey protein has been shown to be particularly 41 
effective for reducing muscle loss and this needs development to provide simple dietary 42 
regimes for the elderly to follow.  There is an ongoing, often too simplistic debate about the 43 
relative value of animal vs. plant food sources for protein in particular. It is important that 44 




evidence on relative functionality which is not expressed in simple nutrient content (e.g. 46 
hypotensive and muscle synthesis stimulation effects). Only by considering such functionality 47 
will a true comparison be achieved. 48 
 49 
Key words: Milk, dairy, life stage, chronic disease 50 
 51 
INTRODUCTION 52 
  53 
In its recent review of world health statistics, the World Health Organization (WHO, 2019) 54 
reports that global life expectancy has continued to increase, on average by 5.5 years from 2000 55 
to 2016, although healthy life expectancy increased by only 4.8 years. There are however great 56 
discrepancies, notably that life expectancy at birth being over 18 years shorter in low income 57 
countries than in high-income countries, with a sizable proportion of the difference being 58 
related to preventable health issues.  Moreover, childhood obesity continues to increase across 59 
the world but most notably in Europe and North America.  60 
 61 
In the United Kingdom (UK), life expectancy doubled over the last 200 years and is now higher 62 
than 80 years (Roser, 2017) with an even greater population growth rate among those aged 85 63 
years and over. Aging brings with it some important nutrition-health challenges such as 64 
increased risk of bone breakages and sarcopenia and those linked to lower absorption of 65 
vitamin B12 and efficiency of vitamin D synthesis. Gullberg et al. (1997) estimated the total 66 
worldwide number of hip fractures to be around 1.26 million in 1990 and they predicted this 67 
would increase to 2.6 and 4.5 million by 2025 and 2050 respectively. In support of this, 68 
Hernlund et al. (2013) reported that the frequency of osteoporotic fracture has increased in 69 




double by 2035. It is therefore of considerable concern that in the UK at least, milk 71 
consumption in teenage years has now reduced, particularly in females, such that considerable 72 
sub-optimal intakes of calcium, iodine and other key nutrients are apparent. 73 
 74 
Sarcopenia is an age-related progressive loss of muscle mass and strength. The meta-analysis 75 
of Shafiee et al. (2017) reported that the overall prevalence of sarcopenia was 10% in males 76 
and females but it was higher in non-Asian than Asian countries.  There are many effects of 77 
sarcopenia including reduced muscle strength and mass leading to increased risk of falls and 78 
related bone breakages which can have major negative impacts on quality of life and 79 
independence. It is also now appreciated that both reduced muscle mass and reduced mobility 80 
can increase the risk of type 2 diabetes which further reduces healthy and quality lifespan 81 
(Hunter et al., 2019).  82 
 83 
In middle and later life cardiovascular diseases (CVD) remain a major cause of death and 84 
morbidity in the EU and worldwide even though prevention and treatment programs have 85 
brought major benefits (Wilkins et al., 2017). While CVD related mortality has declined in 86 
most of Europe, there remain some 49 million people living with CVD in the EU which 87 
represents a major healthcare cost (Wilkins et al., 2017). Of related concern is the substantial 88 
rise in the prevalence of type 2 diabetes related in good part to increased obesity.   Recent data 89 
from Diabetes UK (2019) indicate that about 10% of people over 40 years of age now 90 
have type 2 diabetes with some 4.7 million cases of all types of diabetes (~90% type 2). 91 
It is predicted that by 2030 the number of cases will have reached 5.5 million.   92 
 93 
Diet is a key risk modifying factor for chronic diseases and this must be used appropriately 94 




in later life. The intention of this review to focus on key life stage issues where milk/dairy 96 
components can play a substantial role in reducing chronic disease risk. This predominantly 97 
relates to high income countries although some reference is made to low income countries 98 
where relevant.  99 
 100 
MILK IN CHILDHOOD 101 
Milk and growth 102 
 103 
The benefits of milk in a child’s diets have been known for many years. For example in 1926, 104 
a report produced by the UK Medical Research Council showed that giving an additional 568 105 
mL/day (d) of milk to boys in a children’s residential home led to a marked increase in growth 106 
(Corry Mann, 1926). Subsequently, UK nutrition policy encouraged milk drinking for children. 107 
In recent years there has been an increased focus on the importance of nutrition during 108 
childhood as there is increasing evidence that diets during this period can influence health in 109 
later life. It is well recognized that undernutrition in childhood can lead to a marked reduction 110 
in linear growth (stunting), increased risk of slower short-term cognitive development and in 111 
adulthood of hyperglycemia, hypertension, elevated blood lipids and obesity (de Onis and 112 
Branca, 2016). Despite recent worldwide improvements, Semali et al. (2015) noted that 113 
stunting in sub-Saharan African children remains at about 40 % and some countries have an 114 
even higher prevalence. Recently, Leroy and Frongillo (2019) confirmed that childhood 115 
stunting remains a major health concern in many parts of the world. They also proposed that 116 
the conventional focus on linear growth reduction and stunting is not always the most cost-117 





Nevertheless, a range of studies over a substantial time period have shown milk to be a key 120 
food for reducing stunting in children. In the mid-1970s a randomized controlled trial (RCT) 121 
was started to evaluate the effect of milk provision at school on child growth (Baker et al., 122 
1980). Some 600 children aged 7 and 8 years in families in South Wales, UK with 4 or more 123 
children were chosen from schools in areas with a high socioeconomic deprivation. The 124 
selected children were on average 2.5 cm shorter and 1.5 kg lighter than the average for the 125 
area, and for height, they were representative of the lowest 20% of children throughout the 126 
whole region. The children in the treatment group were given 190 mL of milk every school 127 
day. After 2 school years, these children were significantly taller and heavier (both P<0.01) 128 
than those in the control group although the increases were very small (0.28 cm taller and 0.13 129 
kg heavier). In addition, there was significantly increased growth in children from families in 130 
the highest social classes compared with those in the lowest. More recently, Michaelsen (2013) 131 
emphasized that milk has a specific growth promoting effect in children, an effect which is 132 
seen in both developing and developed countries, indicating an effect even when energy and 133 
nutrient intakes are apparently adequate. In a recent study in Bangladeshi children from 134 
households with milk producing cows, Choudhury and Headey (2018) found that these children 135 
had increased height-for-age Z scores (+0.52 standard deviations) in the crucial 6 to 23 month 136 
growth phase compared with control children from households with non-milk producing 137 
animals, an effect apparently not confounded by family socio-economic status. However, it 138 
was also found that children aged 0–11 months from treatment households were 21.7% less 139 
likely to be breastfed than children from control households, suggesting that ready access to 140 
dairy milk substantially reduces the incentive for mothers to breastfeed. Reduced availability 141 
of breast milk will be a considerable disadvantage for the very young child with the increased  142 





The effect of milk on linear growth is now thought to be primarily mediated through the   145 
stimulation of IGF-1 by milk proteins, in particular by casein (Hoppe et al., 2009). IGF-1 is 146 
essential for longitudinal bone growth, skeletal maturation, and bone mass acquisition during 147 
childhood and maintenance of bone matrix in adult life (Locatelli et al., 2014), with regulation 148 
of bone length associated with changes in chondrocytes of the proliferative and hypertrophic 149 
zones of the growth plate (Yakar et al., 2018). It is of note that Wan et al. (2017) showed that 150 
activation of peroxisome proliferator-activated receptor gamma (PPARγ) is also involved in 151 
the regulation of hepatic IGF-1 secretion and gene expression in response to dietary protein, 152 
thus providing a possible explanation whereby dietary protein and related amino acids 153 
stimulate hepatic secretion of IGF-1. 154 
 155 
Milk, obesity and future health 156 
 157 
The general rise in childhood obesity in many parts of the world is a major concern. At least 158 
60% of children that are overweight before puberty will remain overweight in early adulthood 159 
(Nittari et al., 2019) with the increased risk of CVD (Steinberger et al., 2016) and type 2 160 
diabetes. It is therefore of considerable interest that dairy consumption is inversely and 161 
longitudinally associated with childhood obesity and overweight (Lu et al., 2016; Dougkas et 162 
al., 2019). There are concerns however, about the so-called ‘early protein hypothesis’ with 163 
consistent evidence that the use of infant formulae with higher protein contents than human 164 
milk throughout the first year of life leads to greater abdominal fat mass in children from 2 to 165 
6 years old. This is likely to be related to higher circulating IGF-1 and insulin (Totzauer et al., 166 
2018). Insulin in particular is known to promote adipose tissue deposition and this is a key 167 
component of the early development of insulin resistance. Thus in many Western populations 168 





Milk and bone health 171 
 172 
It is now recognized that sub-optimal vitamin D status in children and adults is prevalent in 173 
many parts of the world. Holick (2010) proposed this to be a pandemic of ‘a forgotten hormone 174 
important for health’. Cashman et al. (2016) confirmed that within Europe, the prevalence of 175 
vitamin D deficiency represented a major health risk which required a major public health 176 
initiative. More recently Jazayeri et al. (2018) reported that the prevalence of vitamin D 177 
deficiency in Iranian children is very high.  178 
 179 
A 2-year intervention study with 757 Chinese females initially aged 10 years compared those 180 
who consumed on school days, 330 mL of calcium-fortified milk with or without a vitamin D3 181 
supplement (5 or 8 µg). Over the intervention period, mean calcium intake was 649, 661, and 182 
457 mg/d for the milk, milk plus vitamin D, and control groups, respectively. Milk 183 
consumption with or without added vitamin D, led to a significantly greater rate of height 184 
increase, body weight, total bone mineral mass, and bone mineral density (BMD). The subjects 185 
who also received vitamin D relative to those receiving just milk showed significantly greater 186 
increases in (size-adjusted) total-body bone mineral content (2·4 v. 1·2%) and BMD (5·5 v. 187 
3·2%.) (Du et al., 2004).  188 
 189 
A study in the United States of America (US) with children aged 4-8 years (Abrams et al., 190 
2014) found that calcium intake, when not substantially deficient, was not highly related to 191 
bone mineral status and that a supplement of 25 µg/d of vitamin D in these children did not 192 
influence calcium absorption or bone mineral status. Intake of magnesium and the amount 193 




that this study is evidence that magnesium should be more considered as an important nutrient 195 
in relation to bone development. The extent to which these findings can be extended to other 196 
populations is at present uncertain, but milk and dairy products are important sources of 197 
magnesium for children (15-25% of intake in UK; Roberts et al.,2018) and are especially 198 
important during the phase of rapid bone growth in late childhood/early adolescence. It is also 199 
of note that low serum magnesium concentrations in males aged 42-61 years were associated 200 
with increased risk of bone fracture in the Japanese Kuopio Ischemic Heart Disease prospective 201 
study (Kunutsor et al., 2017). 202 
 203 
It has been known for a long time that low vitamin D status in children could lead to the 204 
development of rickets and consequent increased risk of osteoporosis in later life. As noted by 205 
Holick (2010), at the start of the 20th century some 80% of children in North America and 206 
Europe suffered from rickets. Subsequently the occurrence of rickets declined markedly as a 207 
result of vitamin D fortification in some countries of foods including milk, and the policy of 208 
providing cod liver oil to children, and by the late 1930s rickets was essentially eradicated. It 209 
is therefore of considerable concern that cases of rickets are again increasing in the US 210 
(Thacher et al., 2013) and worldwide (Prentice, 2013). In the UK, Goldacre et al. (2014) 211 
reported that in England, the need for hospital treatment for rickets was at the highest level 212 
seen in the last 50 years.  213 
 214 
Many, but not all new cases of rickets are the result of sub-optimal vitamin D status with some 215 
cases implicating sub-optimal calcium intake. Milk is of course an excellent dietary source of 216 
calcium and as noted above, milk proteins, especially casein, provide an anabolic stimulus for 217 
bone development (Hoppe et al., 2009). Although milk is not a naturally rich source of vitamin 218 




been a policy in the US and Canada for a long time but in Europe such a policy for liquid milk 220 
is limited to Finland although Sweden and Norway do fortify some dairy products (Itkonen et 221 
al., 2018). Itkonen et al. (2018) also concluded that countries that have a national vitamin D 222 
fortification of milk policy, dairy foods do make a substantial contribution to vitamin D intake 223 
whereas in those with no such policy or with only a few dairy foods fortified, the contribution 224 
is low. Given the evolving picture on rickets, considerably more attention should be focused 225 
on the importance of vitamin D fortification of milk.  There is also concern about the 226 
increasingly popular plant-based milk alternative drinks especially when used to replace milk 227 
for young children (Scholz‑Ahrens et al., 2019). Many contain very little protein, have lower 228 
micronutrient concentrations than milk (Bath et al., 2017) and there have been cases where 229 
young children have become seriously ill as a result of consuming such milk alternatives (e.g.  230 
Fourreau et al., 2013; Le Louer et al., 2014). 231 
 232 
Hypersensitivity to milk and dairy foods 233 
 234 
There are 2 main types of hypersensitivities (often called intolerances) relating to dairy food 235 
consumption i.e. cow’s milk protein allergy (CMPA) and lactose intolerance. These are 2 very 236 
different conditions that require medical diagnosis to avoid unnecessary or inappropriate 237 
removal of cow’s milk from a child’s diet which is a major event that can have significant 238 
nutritional consequences.  239 
 240 
CMPA is an adverse immune response to proteins in cow’s milk with β-lactoglobulin and αs1-241 
casein (both absent in human milk) often being quoted as the 2 key allergenic proteins 242 
(Pastuszka et al., 2016) although many other milk proteins can be involved. CMPA is usually 243 




variants (Vojdani et al., 2018) with anaphylaxis and related death being possible in severe cases 245 
of the rapid onset sub-type (Turner et al., 2015). CMPA is the most common type of food 246 
allergy and usually affects very young children although a high proportion are in remission by 247 
the age of 3 years (Host and Halken, 2014). The increased prevalence of CMPA has been 248 
suggested to be the result of increased use of cow’s milk as a substitute for human milk (Rangel 249 
et al., 2016) although the recent study of Munblit et al. (2020) reports that identification and 250 
management of symptoms as CMPA is often not evidence-based suggesting that there may be 251 
considerable over-diagnosis. 252 
 253 
Lactose intolerance is a non-allergic hypersensitivity that results from a reduced ability to 254 
digest lactose.  Intestinal digestion and absorption of lactose requires the enzyme lactase and 255 
deficiency or insufficiency of lactase leads to malabsorption of lactose and subsequent 256 
digestive upset. The ability or otherwise to synthesize lactase is genetically determined. For a 257 
full and up to date review of lactose intolerance and CPMA the reader is referred to Miles 258 
(2020).    259 
 260 
MILK IN ADOLESCENCE 261 
 262 
Adolescence and dietary change 263 
 264 
Adolescence is the life period (10-19 years, WHO, 1999) involving hormonal changes, rapid 265 
growth and sexual maturation. There are also changing dietary habits, new motivations and 266 
challenges, some persisting into adulthood (Forbes and Dahl, 2010). The age of puberty onset 267 
has reduced substantially over the last 100 years; currently the UK average age for males and 268 





In the UK, data from the National Diet and Nutrition Survey covering the period 2008/09-271 
2011/12 (Bates et al., 2014) identify that adolescent females in particular, have considerably 272 
lower milk consumption than those under 11 years of age while older age groups have 273 
somewhat higher intakes (Figure 1). A similar picture has been seen in the more recent National 274 
Diet and Nutrition Survey covering a longer period 2014/15 to 2015/16 (Roberts et al., 2018) 275 
and this will have contributed substantially to the lower intakes of some key nutrients by 276 
adolescent females (Table 1).  277 
 278 
The reasons for the lower intakes of milk by adolescent females are not known with certainty. 279 
However, poor complexion or weight gain during adolescence is often attributed to milk 280 
consumption. The recent large meta-analysis of RCT on the association between milk/dairy 281 
consumption and body composition in children and adolescents (n=2844; 6-18 years old) does 282 
not support the fattening belief, the primary finding being that consumption of milk/dairy foods 283 
is more likely to produce a lean body phenotype (Kang et al., 2019).  284 
 285 
The very low intakes of magnesium by UK adolescent females are worrying given the evidence 286 
concerning the possible key association between magnesium status and bone mineral status 287 
(Abrams et al., 2014; Kunutsor et al., 2017) summarized above.  Larson et al. (2009) noted that 288 
US National Survey longitudinal data suggest that only 53% of young males and 21% of young 289 
females (19 to 30 years) have calcium intakes that meet recommendations. They also showed 290 
that in the Eating Among Teens (EAT) study both male and female adolescents recorded 291 
significant reductions in calcium intake and dairy food (main reduction was in milk) 292 
consumption from baseline (mean age of 15.9 years) to early adulthood (mean age 20.5 years). 293 
The mean daily reduction in calcium intake was 153 mg and 194 mg for females and males 294 




a liking for milk and peer support for healthy eating at baseline were associated with smaller 296 
reductions in calcium intake (Larson et al., 2009). Given the coexistence of suboptimal vitamin 297 
D status, the above data give rise to considerable concern.  298 
 299 
Milk and bonetrophic nutrients 300 
 301 
The US National Osteoporosis Foundation’s position paper concerning peak bone mass 302 
development (Weaver et al., 2016) emphasized that bone mineral accretion rate becomes rapid 303 
around the time of puberty and reaches its peak a little after achieving maximum height gain. 304 
Weaver et al. (2016) indicated that for children of European ancestry, maximum bone mineral 305 
accretion rate occurs at age of 12.5 ± 0.90 years for females and 14.1 ± 0.95 years for males. 306 
They emphasized that sub-optimal bone mineral accretion in teenage years increases the risk 307 
of osteoporotic fractures in later life, particularly for post-menopausal females. This is 308 
supported by the study of Black et al. (2002) which found that male and female New Zealand 309 
children with a long history of avoiding milk had poor bone health with small bones, low areal 310 
BMD and volumetric bone mineral apparent density, and a high prevalence of bone fractures. 311 
Also, Kalkwarf et al. (2003) used data from 3251 white females in the US National Health and 312 
Nutrition Examination Survey and reported that milk consumption in childhood and 313 
adolescence was positively associated with bone mass in later life and negatively associated 314 
with osteoporotic fracture after 50 years of age. It is of interest that the association between 315 
milk intake in childhood and fracture rate was higher than for milk consumption during the 316 
period of adolescence. This issue was also raised by Feskanich et al. (2014) who, in an analysis 317 
of post-menopausal females in the Nurses’ Health Study, found no association between hip 318 
fractures and milk consumption in teenage years. They queried whether data for milk 319 




maximum height about 2 years sooner than males and are younger at the start of puberty when 321 
bone mineralization doubles (Feskanich et al., 2014). There must also be a question about the 322 
quality of recall of diet data from adulthood back to adolescence and childhood.  323 
 324 
More recently the study by Ma et al. (2014) reported that in Chinese adolescents (12-14 years 325 
of age), females in the high-calcium intake group (mean 1243 mg/d) had greater increases in 326 
BMD of the femoral neck relative to those in the low-calcium intake group (mean 706 mg/d) 327 
over the 12 month intervention period.  A similar effect was observed in males. They proposed 328 
that to increase bone mineral mass, calcium supplementation is more effective in early than 329 
late puberty and that additionally, children should be encouraged to increase their weight-330 
bearing exercise which enhances the effect of dietary calcium.  331 
 332 
The strength of evidence for effects of milk/bonetrophic nutrients on bone development in 333 
adolescents is fairly strong but there remains more uncertainty about the effect on bone health 334 
in middle and later life following long term exposure to diets low or devoid of milk/dairy. Also, 335 
a recent systematic review and meta-analysis of the associations between vegan and vegetarian 336 
diets and bone health gives further evidence on the chronic effect of diets containing low or 337 
zero milk and dairy products (Iguacel et al., 2018). Twenty studies of adequate quality were 338 
included in the meta-analysis of Iguacel et al. (2018) which included 37,134 participants of 339 
which 33,131 had data on fracture rate and 4003 data on BMD. Overall, compared with 340 
omnivores, vegetarians and vegans had significantly lower BMD at the femoral neck, lumbar 341 
spine and whole body, with vegans generally exhibiting lower BMD than vegetarians (Table 342 
2).  Vegans also had a higher relative risk (RR) for fracture rate (RR: 1.44; 95% confidence 343 




the absolute need for careful, detailed and long-term planning of vegetarian and vegan diets in 345 
order reduce the risk of negative effects on bone health. 346 
 347 
A very recent review on milk and bone health (Batty and Bionaz, 2019) has provided some 348 
new thinking on the mechanisms concerning the role of milk in bone development including 349 
the possible role of micro-RNA (miRNA) contained in milk. While there appears to be 350 
considerable, but building evidence that endogenous miRNA is involved in regulation of 351 
osteoblastic differentiation and other pathways relevant to bone development in adolescents, 352 
there remains uncertainly about the effect of miRNA provided by the diet in the form of 353 
exosomes. Zempleni (2017) has shown that exosomes are absorbed and can accumulate in 354 
peripheral tissues but the functionality of their miRNA is unclear. At present the possible 355 
involvement of milk-derived exosomes/miRNA in bone development and maintenance 356 
remains speculative and is clearly a target for further research. 357 
 358 
MILK AND PREGNANCY 359 
 360 
Iodine status during pregnancy 361 
 362 
In the UK and many other countries milk and milk products are the biggest dietary source of 363 
iodine by a considerable margin. The recent UK National Diet and Nutrition Survey (Year 8, 364 
20114/15-15/16; Roberts et al., 2018) reports that milk and milk products contribute 40% and 365 
34% of dietary iodine intake for 11-18 years and 19-64 years age groups respectively, with 366 
liquid milk being the primary dairy source. Fish are the next largest contributor to dietary intake 367 




most important determinant of iodine status in US adult (≥ 20 years) males and females, despite 369 
the availability of iodized salt (Lee et al., 2016). 370 
 371 
Until fairly recently it was believed that the UK population was of adequate iodine status. 372 
However, a study which measured iodine concentrations of urine from UK schoolgirls showed 373 
51% of them to be mildly iodine deficient (Vanderpump et al., 2011). As noted earlier, 27% of 374 
adolescent females (11-18 years) have iodine intakes below the Lower Reference Nutrient 375 
Intake (70 µg/d), while the mean value for females 19-64 years is 15% (Roberts et al., 2018; 376 
Table 1) but given the milk intake values in Figure 1, females of childbearing age are likely to 377 
exceed this value substantially. Of particular concern are the results from a study in a large UK 378 
cohort of pregnant females which showed consistent mild-to-moderate iodine deficiency (Bath 379 
et al., 2014) with similar findings in pregnant Norwegian females (Brantsæter et al., 2013). 380 
Bath and Rayman (2015) reviewed the then current evidence on the iodine status of pregnant 381 
females in the UK and the risks to child development after birth (as discussed below) associated 382 
with below optimum status. They concluded that a substantial proportion of UK pregnant and 383 
non-pregnant women were iodine deficient. The WHO database on iodine deficiency (WHO, 384 
2020) highlights that large parts of the world are affected with substantial parts of Africa and 385 
Asia having mild or moderate deficiency. Example studies include one from Tanzania that 386 
reported an unacceptably high prevalence of iodine deficiency among pregnant females 387 
(Abdalla et al., 2017) and a recent assessment on the iodine status of teenage females on the 388 
island of Ireland (Mullan et al., 2019) showed that this population were at ‘the low end of 389 
sufficiency’ which clearly has implications for their future progression into pregnancy and for 390 
child development after birth (as discussed below). 391 




Bath and Rayman (2015) also discussed the potentially contributing fact that UK 393 
recommendation for iodine intake of 140µg/d for adults (Department of Health, 1991) is not 394 
only lower than WHO et al. (2007) recommends for non-pregnant/non-lactating adults and 395 
adolescents (>12 years of age) (150µg/d) but it does not increase during pregnancy (or 396 
lactation) whereas WHO et al. (2007) recommends an increase to 250µg/d.  There are clear 397 
needs for a greater iodine intake during pregnancy including the demands associated with 398 
substantially increased maternal thyroid hormone production in early pregnancy and later for 399 
the fetus when it is able to synthesize thyroid hormones (Bath and Rayman, 2015).  400 
 401 
It is concerning to note that that there are now a number of studies from several countries 402 
including Spain (Costeira et al., 2011), The Netherlands (van Mil et al., 2012), Australia (Hynes 403 
et al., 2013) and the UK (Bath et al., 2013) that have found a significant association between 404 
low maternal iodine status in early pregnancy and poorer cognitive performance/neurological 405 
development in the children.  A systematic review and meta-analysis found that low maternal 406 
iodine status was associated with 6.9 to 10.2 lower IQ points in children <5 years of age 407 
(Bougma et al., 2013). They concluded that independent of study type, low iodine status had a 408 
major effect on mental development. It is also worth recording that Businge et al. (2019) 409 
reported that although sub-clinical hypothyroidism during pregnancy is one of the key risk 410 
factors for pre-eclampsia, the connection between sub-optimal iodine status and pre-eclampsia 411 
remains uncertain. Given the risks associated with pre-eclampsia, Businge et al. (2019) 412 
proposed that a systematic review and meta-analysis on the subject should be undertaken. 413 
 414 
Given the potentially serious implications of sub-optimal iodine status on child development, 415 
there is a clear need for more precise RCT to give more definitive evidence on the need for 416 




offspring. Such studies would no doubt raise important ethical considerations, but it is 418 
interesting to note that in the study of Bath et al. (2014), only females consuming more than 419 
280 ml of milk/d had achieved adequate iodine status and a recent RCT in low-moderate (<250 420 
mL/d) milk consuming females showed that increasing consumption to 459 mL/d (3L/week) 421 
of semi-skimmed (fat reduced) milk significantly increased their iodine status (O’Kane et al., 422 
2018). The volume of milk needed to achieve an adequate iodine intake will clearly depend on 423 
its iodine concentration which can be substantially variable.  424 
 425 
Factors affecting the iodine concentration in milk 426 
 427 
Survey studies on UK milk iodine concentrations (Food Standards Agency, 2008) do not 428 
suggest that milk iodine concentration has declined but they do show that milk produced in the 429 
summer has on average, a 50% lower iodine concentration than winter milk. Moreover, 4 UK 430 
studies (Food Standards Agency, 2008; Bath et al., 2012; Payling et al., 2015; Stevenson et al., 431 
2018) and the meta-analysis of Średnicka-Tober et al. (2016) all reported that milk from 432 
organic dairy systems had significantly lower iodine concentrations than from conventional 433 
systems. The interacting involvement of season and production system on milk iodine 434 
concentration can be seen in Figure 2 from Stevenson et al. (2018). The review of Flachowsky 435 
et al. (2014) confirms that the iodine intake by the dairy cow has the primary influence on milk 436 
iodine concentration. Since most iodine is provided to the cow by concentrate feeds, this would 437 
explain the lower values reported in milk in the summer and from organic systems, since the 438 
animals in both situations are likely to be provided with less concentrate feeds. The effect of 439 
iodine supplements (30 or 70 mg/d) to dairy cows were compared to a control (0 mg/d). Iodine 440 
concentration increased ~2 fold in the milk of the supplemented animals compared with the 441 




(O’Brien et al., 2013). It is important to note that the iodine concentrations in milk from the 443 
iodine-supplemented diets were much higher (up to 1034 µg/kg) than is desirable for 444 
processing into infant formula products. As the authors point out, the supplemented diets did 445 
not contain more iodine than the maximum prescribed in the present EU legislation (5 mg 446 
iodine/kg diet at 12% moisture; European Commission, 2005). O’Brien et al. (2013) also 447 
showed that the use of iodine-containing teat disinfection products both pre- and post-milking 448 
increased milk iodine concentration (P < 0.001) at all of the dietary iodine supplementation 449 
amounts. This and a number of additional factors which influence milk iodine concentration 450 
are extensively reviewed by Flachowsky et al. (2014).  451 
 452 
Overall, knowledge on the relationship between iodine in the dairy cow diet and milk iodine 453 
concentration, together with other factors, provides a means to produce milk with the required 454 
iodine concentration for consumption by adults but avoiding concentrations too high for 455 
children. 456 
 457 
MILK IN ADULTHOOD 458 
 459 
Milk consumption and body composition 460 
 461 
The prevalence of overweight and obesity (body mass index (BMI) of 30 kg/m2 or more) 462 
continues to rise worldwide. OECD (2017) reports that since the 1990s overweight and obesity 463 
rates have increased substantially in England, Mexico and the US although the increase has 464 
been somewhat slower in the other 7 OECD countries for which data are available. It was also 465 




with for example <6% in Korea and Japan but up to >30% in Hungary, New Zealand, Mexico 467 
and the US.  468 
 469 
Obesity is a major risk factor for chronic diseases, particularly diabetes, CVD, stroke and some 470 
cancers. The association between obesity/overweight and type 2 diabetes is particularly critical, 471 
accounting for up to some 70-90% of the risk for type 2 diabetes (Hu et al., 2001; Gatineau et 472 
al., 2014), although there remains some uncertainty why some obese subjects do not develop 473 
type 2 diabetes (Abdullah et al., 2010).  474 
 475 
It is not the intention of this paper to review in detail all the evidence on the association between 476 
milk/dairy and obesity. There is however, a large amount of evidence from observational, 477 
cross-sectional, and prospective studies which is consistent with a negative association between 478 
dairy consumption and both body weight and central obesity (Dougkas et al., 2011). The review 479 
of Kratz et al. (2013), using observational and RCT evidence, found that in 11 out of 16 studies, 480 
high-fat dairy consumption was inversely associated with measures of adiposity whereas the 481 
association between high-fat dairy and metabolic health was either inverse or had no 482 
association. The recent report on middle-aged males (at baseline) in the Caerphilly Prospective 483 
Cohort showed no association between milk consumption and BMI, but higher cheese 484 
consumption was associated with lower BMI at the 5-year follow-up (P=0.013) (Guo et al., 485 
2018).  486 
 487 
Many RCT have evaluated the association between dairy consumption and body weight and 488 
fat mass, but the majority have been small and of limited duration and although some have 489 
included energy restriction, others have focused on weight maintenance with the overall 490 




showed that while the inclusion of dairy foods in weight maintenance diets is not associated 492 
with weight loss or weight gain, there were weight loss benefits from the combination of these 493 
foods and energy-restricted diets (Chen et al., 2012). 494 
 495 
Milk consumption, stroke, cardiovascular and metabolic diseases 496 
 497 
It is interesting to note that while in most high income countries the prevalence of death from 498 
CVD has reduced considerably over recent decades, it is concerning that recent data from the 499 
US indicate a levelling off of the decline, thought probably a result of increasing obesity and 500 
related type 2 diabetes (Zia et al., 2018).  These data highlight the risk of complacency and the 501 
continued need for the management of lifestyle including diet. In this regard and as noted 502 
above, the impact of dairy foods in the diet is poorly understood by many in the general 503 
population. 504 
  505 
Evidence from prospective studies. Many prospective studies have investigated the association 506 
between milk and dairy product consumption and cardiometabolic diseases (CMD, includes 507 
CVD, stroke and type 2 diabetes).  Data from prospective cohort studies are usually regarded 508 
as providing poorer evidence than that from RCT since they only estimate risk and cannot 509 
prove cause and effect, but they do have the advantage of looking at chronic effects and use 510 
hard disease data outcomes. Another limitation of this type of study is the presence of variables 511 
(confounders) which are beyond the control of the researchers (e.g. some subjects may be 512 
smokers, some will not) but which can influence the variables being studied (e.g. the effect of 513 
cheese consumption on the risk of CVD) leading to results which do not represent the actual 514 
association. This is normally dealt with by including the confounder in the statistical model 515 




residual confounding not accounted for. Long-term RCT using hard disease endpoints would 517 
be impractical, very costly and likely with high subject dropout rates with the result that most 518 
RCT are relatively short term and use markers of disease risk such as low density lipoprotein 519 
cholesterol (LDL-C) as primary outcome measures. Meta-analysis of prospective data is a 520 
valuable tool for investigating the overall associations between dairy food consumption and 521 
CMD risk, although there is a concern that in many studies these foods are poorly defined, 522 
especially their fat content, which limits assessment of any differential effects.  523 
 524 
While there have been several other meta-analyses published over recent times, a series of 525 
dose-response meta-analyses was published in 2016/17 examining the association between 526 
dairy food consumption and type 2 diabetes (Gijsbers et al., 2016), stroke (de Goede et al., 527 
2016), and CVD and all-cause mortality (Guo et al., 2017). The availability of new data has 528 
allowed key components of these meta-analyses to be updated (Soedamah-Muthu and de 529 
Goede, 2018) and the outline results are presented in Table 3.  530 
 531 
Overall, these prospective studies show no increase in risk of coronary heart disease (CHD) 532 
and stroke per 200g increase in total dairy and milk. Interestingly, milk and yogurt consumption 533 
was associated with a substantially reduced risk of stroke and type 2 diabetes respectively. The 534 
reduced risk of type 2 diabetes associated with yogurt consumption is also highlighted in the 535 
recent review of evidence of Guo et al. (2019). There are few studies which have looked into 536 
the association between butter consumption and CMD although the dose-response meta-537 
analysis of Pimpin et al. (2016) showed no significant association between butter consumption 538 
and all-cause mortality, CVD, CHD specifically, or stroke, although there was a significant 539 
negative association with type 2 diabetes. This meta-analysis involved only a few cohorts for 540 




inclusion for type 2 diabetes. More recently, Griffin and Lovegrove (2018) raised the 542 
possibility that increased high density lipoprotein-mediated cholesterol efflux capacity 543 
compensates for the adverse effect of saturated fatty acids (SFA) in butter in raising blood 544 
LDL-C. 545 
 546 
The Prospective Urban Rural Epidemiology (PURE) study recently published its results 547 
(Dehghan et al., 2018). PURE is a multinational cohort study of 136,384 subjects aged 35-70 548 
years from 21 countries (6, 11, 4 low, middle and high income respectively) across 5 continents, 549 
which examined the association between consumption of dairy foods (total and milk, yogurt, 550 
and cheese) with mortality and CVD. Higher intake of total dairy foods (>2 servings/d vs. none) 551 
was associated with a lower risk of non-CVD mortality (hazard ratio (HR) 0.86, 95% CI 0.72-552 
1.02; Ptrend = 0.046), CVD mortality (HR 0.77, 95% CI 0·58-1·01; Ptrend = 0·029), major CVD 553 
events (HR 0.78, 0.67-0.90;  Ptrend = 0·0001), and stroke (HR 0.66, 0.53-0·82;  Ptrend = 0·0003). 554 
Greater consumption of milk and yogurt, but not cheese, was associated with a lower risk of 555 
the combination of mortality or major CVD events.  Although the results from PURE are 556 
largely in agreement with earlier studies and meta-analyses, it is believed to be the first study 557 
of its kind to involve such large and diverse cohorts of subjects with substantial variation in 558 
habitual dairy and other dietary component intake between regions and countries. 559 
 560 
Overall, the findings from meta-analyses of prospective cohort studies provide no evidence of 561 
an increased risk of CMD associated with increased consumption of dairy foods despite most 562 
of these foods making a major contribution to SFA intake. These findings may seem 563 
counterintuitive in view well-established link between LDL-C and CVD. There is however 564 




differential effects of different SFA and the food matrix influences (Thorning et al., 2017; 566 
Astrup et al., 2019). 567 
 568 
A number of prospective studies have also examined the association between milk/dairy intake 569 
and blood pressure. For example, findings from the Caerphilly Prospective Study indicate that 570 
after a 22.8 year follow-up, men who consumed >586 mL/d of milk had a mean lower systolic 571 
blood pressure of 10.4 mmHg, compared with non-milk consumers (Ptrend = 0.033) 572 
(Livingstone et al., 2013). 573 
 574 
Evidence from randomized controlled trials. The American Heart Association recently 575 
reported that in 2015 the proportion of US adults ≥18 years of age with diagnosed hypertension 576 
was 29.7% (age adjusted) although there was considerable variability with equivalent values 577 
ranging from 24.2% for Minnesota to 39.9% for Mississippi (Benjamin et al., 2018). Data from 578 
2016 in England indicate that 28 % of adults had diagnosed hypertension (National Statistics, 579 
2017a). In addition, there are substantial numbers of individuals with undiagnosed 580 
hypertension. Hypertension is one of the major risk factors for CVD and for stroke in particular.  581 
 582 
There is now good evidence that the proteins in milk and milk derived products have beneficial 583 
hypotensive effects, particularly whey proteins. This has been shown in vitro (Giromini et al., 584 
2017) and in vivo. An 8-week RCT (Fekete et al., 2016) found that whey protein isolate (2 x 585 
28g/d) had a larger hypotensive effect than casein with effects seen on both central and 586 
peripheral blood pressures. Whey protein was also shown to have a greater effect than casein 587 
in an acute setting (Fekete et al., 2018). A number of mechanisms by which milk and its 588 
components could lower blood pressure have been proposed including the effects of dairy 589 




effect of milk protein-derived peptides  (Fekete et al., 2013). A number of peptides released 591 
during digestion of casein and whey proteins possess hypotensive activity through inhibiting 592 
the action of the angiotensin-1-converting enzyme that would normally increase the production 593 
of angiotensin-2 which has a vasoconstricting effect leading to increased blood pressure 594 
(FitzGerald and Meisel, 2000; Giromini et al., 2019). Other effects of milk protein-derived 595 
peptides may be important such as binding with opioid receptors thus increasing nitric oxide 596 
production which mediates arterial tone and thus reduces blood pressure (Kris-Etherton et al., 597 
2009).  598 
 599 
Recent work on hemodynamics has shown that arterial stiffness, especially of the central large 600 
vessels, is a valuable predictor of future CVD events (Cockcroft and Wilkinson, 2000). Milk 601 
and dairy consumption have been shown to be associated with reduced arterial stiffness. 602 
Livingstone et al. (2013), working with the Caerphilly Prospective Study, showed, it is believed 603 
for the first time in a longitudinal study, that augmentation index (an indirect measure of arterial 604 
stiffness) was 1.9% lower in subjects with the highest dairy product consumption (not including 605 
butter) compared with the lowest (Ptrend = 0.021) after a mean follow up period of 22.8 years. 606 
A similar effect was seen in a cross-sectional study that showed a negative association between 607 
milk/dairy consumption and pulse wave velocity (another indirect measure of arterial stiffness, 608 
Crichton et al., 2012). More recently, the specific effect of milk proteins together with exercise 609 
has been shown to reduce arterial stiffness in pre-hypertensive and hypertensive young females 610 
(Figueroa et al., 2014). Whey protein and casein both significantly (P< 0.05) reduced arterial 611 
stiffness as indicated by reduced augmentation index by about 9.2% and 8.1%, respectively 612 
and reduced pulse wave velocity by 57 cm/s and  53 cm/s, respectively compared with no 613 





Food matrix effects of dairy products on blood lipids. New evidence on the food matrix goes 616 
a considerable way to explaining the lack of effect of dairy SFA on CVD risk. This topic has 617 
been extensively discussed recently by Astrup et al. (2019) and will not be fully repeated here, 618 
but aspects of food matrix effects are worthy of mention.  619 
 620 
Traditionally, nutritional evaluation of foods and diets and their links with the health/disease 621 
of the consumer has normally been assessed on separate considerations of food components, 622 
notably protein, fat, carbohydrates and micronutrients. For some dairy foods there is now good 623 
evidence that this approach is not appropriate and indeed may mislead since the modifying 624 
effects of the so-called food matrix needs to be considered. This subject was extensively 625 
reviewed by an expert working party jointly established by the Universities of Copenhagen and 626 
Reading and the outcome has been published (Thorning et al., 2017).   627 
 628 
A good illustration of the differential matrix effects on blood lipids of SFA from hard cheese 629 
and butter is reported in the RCT of Hjerpsted et al. (2011). This involved two 6-week crossover 630 
periods with 49 males and females replacing part of their habitual dietary fat with 13% of 631 
energy from cheese or butter (both providing 80 g/d and 36 g/d of total fat and SFA, 632 
respectively). Crucially, the cheese and butter diets provided 1192 g and 417 g of calcium/d, 633 
respectively. Compared with baseline, cheese did not increase blood total cholesterol or LDL-634 
C whereas the butter diet increased both of these (P<0.001, 0.05 respectively). The cheese diet 635 
led to a 5.7 and 6.9 % lower total cholesterol or LDL-C concentrations respectively, than the 636 
butter diet (P< 0.0001). The recently published and rather unique study of Feeney et al. (2018) 637 
attempted to explore the matrix effect in a stepwise-response fashion. The study was a 6-week 638 
randomized parallel design where subjects consumed 40 g of dairy fat/d in macronutrient-639 




cheese plus 31 g of butter, or 3) 49 g butter plus 30 g calcium caseinate and 500 mg of calcium 641 
as CaCO3.  The blood lipid responses are summarized in Table 4 but the results did indeed 642 
show a stepwise-matrix effect with significantly lower post-intervention total cholesterol and 643 
LDL-C concentrations seen when all of the dairy fat was provided by the cheese.  644 
 645 
Several mechanisms have been proposed as being responsible for the benefits of the so-called 646 
matrix effect and these are reviewed in detail by Thorning et al. (2017). In brief, most studies 647 
involving hard cheese result in increased fecal fat and calcium excretion which, in part at least, 648 
seems to be the result of a saponification reaction in the gut between calcium and fatty acids 649 
leading to largely indigestible soaps. There is also evidence that fecal bile acid excretion is 650 
increased due to adsorption on amorphous calcium phosphate formed from dietary calcium and 651 
phosphorus. This reduces the enterohepatic recycling of bile acids thus increasing bile acid and 652 
fat excretion. Since the liver synthesizes bile acids from cholesterol, reduced bile acid recycling 653 
may also lead to reduced circulating cholesterol.  There is also evidence of a role for the milk 654 
fat globule membrane apparently protecting fat from digestion.  A good example of this is in 655 
the study of Rosqvist et al. (2015).  656 
 657 
These studies clearly confirm that the effect of dairy foods on CVD risk factors, primarily blood 658 
lipids, are influenced by the food matrix, even  when compared with foods providing the same 659 
amount of dairy fat and SFA.  However, most of the evidence available relates to hard cheese 660 
vs. butter and as proposed by Thorning et al. (2017), more research is required to more fully 661 
understand food matrix effects on health and how these relate to specific dairy foods and 662 





MILK AND DAIRY PRODUCTS FOR THE ELDERLY 665 
 666 
Dairy proteins and sarcopenia 667 
 668 
Sarcopenia: the condition. Sarcopenia is a condition characterized by a mainly chronic 669 
ongoing loss of muscle mass and muscle strength with advancing age (Cruz-Jentoft et al., 670 
2019). It is therefore a condition of particular importance in the elderly (though not exclusively) 671 
with an increasing prevalence mainly associated with the increasing age of populations 672 
worldwide.  Sarcopenia can have far reaching consequences since, for example, it reduces bone 673 
protection increasing the risk of breakage in a fall leading to reduced mobility, disability and 674 
lower quality of life. A less well known outcome of reduced muscle mass and possibly 675 
associated reduced exercise ability is the increased risk of metabolic diseases, type 2 diabetes 676 
in particular (Hunter et al., 2019).  677 
 678 
Based on general population studies, Shafiee et al. (2017) published a meta-analysis on the 679 
prevalence of sarcopenia worldwide involving a total 58,404 generally healthy subjects >60 680 
years of age.  This study showed a mean prevalence of 10% in both males and females, with a 681 
higher value in non-Asian than Asian populations with the non-Asian values (~20%) being 682 
about double those of Asians when Bio-electrical Impedance Analysis was used to estimate 683 
muscle mass. 684 
 685 
The role of dietary proteins for reducing sarcopenia. Consumption of protein and resistance 686 
exercise are both known to provide an anabolic stimulus for skeletal muscle protein synthesis 687 




consumption and exercise needed to stimulate muscle protein synthesis in the elderly. In the 689 
UK, the Reference Nutrient Intake for protein is equivalent to 0.75g/kg body weight, slightly 690 
less than the Recommended Dietary Allowance (RDA) of 0.8 g/kg body weight proposed for 691 
males and non-pregnant and non-lactating females >18 years of age by the FAO/WHO/UNU 692 
(2007). These recommendations take no account of specific age or health status and Lonnie et 693 
al. (2018) have discussed  and highlighted the relevance of new recommendations suggesting 694 
protein requirements of 1.0-1.2, 1.2-1.5 and 2.0 g/kg body weight respectively for people >65 695 
years, for those with acute/chronic illnesses and those with severe illness or malnutrition 696 
respectively. The review of Lonnie et al. (2018) cites work which confirms that intake of 697 
protein in accordance with the RDA has led to deleterious health outcomes including a 14-698 
week RCT in subjects aged between 55 and 77 years who consumed the FAO/WHO/UNU 699 
RDA of 0.8 g protein/kg bodyweight which led to a reduced mid-thigh muscle area and other 700 
characteristics suggesting the protein intake was below requirement (Campbell et al., 2001). 701 
This is concerning since in the UK the latest National Diet and Nutrition Survey (Roberts et 702 
al., 2108) indicates a mean protein intake of 75.8 g/d (males) and 60.5 g/d (females) 65+ years 703 
old, which with a mean bodyweights for this age group of 85.8 kg (males) and 71.5 kg (females) 704 
(National Statistics, 2017b), equates to 0.88 and 0.85 g protein/kg bodyweight for males and 705 
females respectively.   706 
 707 
Overall, there is considerable agreement of the benefits from increasing protein intake to 1.0 708 
g/kg body weight or higher by the elderly, yet there have been concerns that the strong satiating 709 
effect of protein may limit total food and energy intake. In addition there have been concerns 710 
that higher protein intake may adversely affect individuals with chronic kidney disease which 711 
may be undiagnosed. The meta-analysis of Devries et al. (2018a) compared the effect of low 712 




diets and showed no effect on kidney function in subjects with normal function and in those 714 
with type 2 diabetes who would have a greater risk of chronic kidney disease.  Nevertheless, it 715 
is probably wise for the elderly to have regular tests of kidney function irrespective of diet.  716 
 717 
Type of dietary proteins for reducing sarcopenia. There has been considerable research on the 718 
relative anabolic effects of specific protein types. Wall et al. (2014) concluded that proteins 719 
such a whey protein which are rapidly digested and absorbed lead to greater muscle protein 720 
synthesis than from slower digested proteins like casein and those in soya. They also note that 721 
even when casein is hydrolyzed to increase digestion rate, the muscle protein response is still 722 
smaller than from equivalent amounts of whey protein. This is primarily attributed to the higher 723 
leucine content of whey protein, the specific effect of leucine having also been seen in studies 724 
using leucine supplements (Wall et al., 2013; Devries et al., 2018b).  The effect of leucine is 725 
complex. It is an important activator of the mammalian target of rapamycin (mTOR) a nutrient-726 
sensing signaling pathway in skeletal muscle. In addition, leucine is insulinotrophic and the 727 
additional insulin enhances muscle protein synthesis (Paddon-Jones and Rasmussen, 2009). 728 
There is evidence however, that consumption of 40g of casein before sleep increases muscle 729 
protein synthesis rates during overnight sleep in older males (Kouw et al., 2017). This is 730 
potentially important as overnight is generally a period of negative whole body protein net 731 
balance.   732 
 733 
A number of studies have compared the relative value of plant proteins compared with whey 734 
protein. The study of Yang et al. (2012) compared the response in myofibrillar protein 735 
fractional synthetic rate (FSR) in rested elderly males resulting from 0, 20 or 40g of either 736 
whey protein or soya protein. Myofibrillar FSR did not respond to consumption of 40g soya 737 




protein. A similar differential effect was seen when the protein supplements were given post-739 
exercise.  740 
 741 
Magnesium and sarcopenia. As with the influence of magnesium intake on bone 742 
mineralization noted earlier, there is also increasing evidence of an association between 743 
magnesium and preservation of skeletal muscle. With a large cohort of 156,575 males and 744 
females aged 39-72 years, Welch et al. (2017) examined cross-sectional associations between 745 
magnesium intake and skeletal muscle mass (as fat-free mass % body mass (FFM%)) and grip 746 
strength. They showed positive associations between quintiles of magnesium intake and FFM% 747 
(P trend < 0.001) and grip strength (P trend <0.001). The association with grip strength was 748 
greater in older (60 years of age or older) than younger males although the opposite was the 749 
case for females.   750 
 751 
Despite being a cross-sectional study, it was, according to the authors, the largest population 752 
to date used to study the association between magnesium intake and direct measures of skeletal 753 
muscle. Milk and milk products are important sources of magnesium contributing some 13% 754 
to diets of the elderly (Roberts et al., 2018) and in the US it was reported that consuming the 755 
recommended quantities of dairy would significantly reduce the prevalence of low magnesium 756 
intake (Quann et al., 2015). Erem et al. (2019) highlighted that magnesium intake is particularly 757 
low in the elderly US population which is similar to the UK where 25% of individuals 75 years 758 
old and above consume less than the Lower Reference Nutrient Intake. Clearly more work on 759 
this is needed but this study adds to increasing importance of magnesium in muscle and bone 760 





Dairy foods and bone fragility 763 
 764 
Type of dairy foods. Unlike the situation with the young, the effect of dairy foods on bone 765 
strength in the elderly is less clear.  A meta-analysis of 6 cohorts reported a 17% increased risk 766 
of hip fracture in males and females who consumed less than 1 glass of milk per day although 767 
the change was not significant (Kanis et al., 2005) and a later meta-analysis including a further 768 
6 cohorts found no association between milk consumption and hip fracture risk (Bischoff-769 
Ferrari et al., 2011). More recently, data from the Framingham Original Cohort (mean age at 770 
baseline 75 years) showed that higher milk and milk+yogurt+cheese intakes were associated 771 
with higher lumber spine BMD (P=0.011, 0.005) and higher milk+yogurt+cheese intakes 772 
protected against trochanter BMD loss (P=0.009) over 4 years. In all cases, the significant 773 
beneficial associations were only seen in subjects that were vitamin D supplement users (Sahni 774 
et al., 2014). The results from a Swedish female cohort indicated a significant 9% increased 775 
risk of hip fracture per glass of milk per day while no effect was seen in a male cohort 776 
(Michaëlsson et al., 2014). The reasons for the positive associations in the females are unclear. 777 
 778 
More recently, the analysis of 2 US cohorts containing 80,600 post-menopausal females and 779 
43,306 males greater than 50 years of age at baseline that were followed up for 32 years 780 
reported that for females and males combined, each serving of milk/d was associated with a 781 
8% lower risk of hip fracture (RR 0.92, 95% CI 0.87-0·97) compared with those that consumed 782 
less than 1 serving per week (Feskanich et al., 2018). The authors suggested that a major 783 
strength of the study was that multiple measures of milk and dairy food intake were made over 784 
the 32 years of follow-up allowing long term mean intakes to be estimated.  Calcium, vitamin 785 
D and protein from non-dairy and dairy sources did not influence the association between milk 786 




dietary pattern classified as ‘milk/dairy’ led to the greatest reduction in risk of low BMD 788 
compared with patterns classified as ‘healthy’ and ‘meat/Western’ and the effect remained 789 
significant in older females (Fabiani et al., 2019).  790 
 791 
Ong et al. (2019) conducted a systematic review on fermented milk products (yogurt and 792 
cheese) and bone health in post-menopausal women. The analysis included RCT, prospective 793 
cohorts and case-control studies. Overall, only increased yogurt consumption was associated 794 
with a reduced risk of hip fracture when compared with little or no intake. The evidence for 795 
cheese was limited and suggests that further work to understand the effect of yogurt is needed. 796 
 797 
Magnesium and bone health. The possibly important role of dietary magnesium for bone 798 
development in young people was discussed earlier but there is now some evidence of a similar 799 
benefit in later life.  The review of Erem et al. (2019) highlights that the risk of osteoporosis in 800 
older people can result from low intake of magnesium which gives rise to excess calcium 801 
release from bone and increased excretion which increases bone fragility and hence a higher 802 
risk of bone fractures. Also, high intakes of calcium can lead to lower retention of magnesium 803 
and Erem et al. (2019) suggest that the optimal dietary ratio of calcium:magnesium is between 804 
2.0:1.0 and 2.8:1.0 but in many current US diets the ratio above 3.0:1.0.  805 
 806 
There is an obvious need to further explore the role of magnesium and its interaction with 807 
calcium and vitamin D in relation to bone strength in the elderly. Dairy products are a good 808 
source of calcium and for many an important source of magnesium along with vitamin D when 809 







Despite a favorable ongoing increase in life expectancy, an increase in healthy lifespan is not 814 
assured and indeed some of the health issues in aging populations arise because of longer life. 815 
Moreover, there is now increasing evidence that diets in early life can influence health in older 816 
life stages. There is good evidence that milk and dairy foods are important sources of nutrients 817 
some of which are particularly important at certain life stages. The concentration of some 818 
nutrients, notably iodine, are also dependent in the diet of the milk producing animal, a good 819 
example of an early stage in the food chain having an influence on  nutrient intake. The reduced 820 
milk consumption, notably by adolescence females, is a major worry since it may have already 821 
had an impact on bone development such that reduced bone strength may become evident when 822 
they are much older. Despite being counterintuitive to many, there is now consistent evidence 823 
that consumption of milk/dairy foods does not increase the risk of CMD, indeed a number of 824 
significant negative associations with risk of this group of diseases have been reported. The 825 
negative and positive associations of yogurt with type 2 diabetes and bone strength respectively 826 
are particularly interesting given the rapid rise in prevalence of type 2 diabetes and bone 827 
weakness and these should be researched with urgency to identify the mechanisms involved 828 
and to develop yogurt with targeted efficacy. Much greater effort is also needed to reduce 829 
malnutrition in the elderly and to reduce the loss of muscle mass, bone strength and 830 
functionality and this seems to provide good opportunities for dairy products to play a key role. 831 
There is of course an ongoing debate about the relative sustainability of animal vs. plant food 832 
sources. While it makes sense to examine this tradeoff, it is important that judgements on the 833 
replacement of dairy products with those from plants include evidence on relative functionality 834 
(e.g. hypotensive and muscle protein synthesis stimulation effects) and not only on simple 835 
comparisons of nutrient content (Grant and Hicks, 2018). Interestingly, a very recent, detailed 836 




dietary pattern with increased dairy consumption by US adults would have the potential to save 838 
billions of dollars (Scrafford et al., 2020). 839 
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Table 1. Percentage of 3 UK population groups with micronutrient intakes less than the Lower Reference Nutrient Intake (LRNI) and percentage 1296 
achievement of the Reference Nutrient Intake (RNI) for vitamin D (Adapted from data in Roberts et al., 2018). 1297 
 % with intakes less than the LRNI for:  % RNI 
Population Iron Calcium Magnesium Zinc Selenium Iodine  Vitamin D 
Males 11-18 years 12 11 27 18 26 14  20 
Females 11-18 years 54 22 50 27 45 27  17 





Table 2.  Effects of vegetarian and vegan relative to omnivore diets on bone mineral density 1299 
(BMD) at the lumbar spine, femoral neck and of whole body. (Adapted from data in Iguacel 1300 





95% CI1 P2 
At the lumbar spine    
Vegetarians + vegans vs. omnivores -0.032 -0.048, -0.015 <0.05 
Vegetarian vs. omnivores -0.023 -0.035, -0.010 <0.05 
Vegans vs. omnivores -0.070 -0.116, -0.025 <0.05 
    
At the femoral neck    
Vegetarians + vegans vs. omnivores -0.037 -0.054, -0.020 <0.05 
Vegetarian vs. omnivores -0.025 -0.038, -0.012 <0.05 
Vegans vs. omnivores -0.055 -0.090, -0.021 <0.05 
    
Whole body    
Vegetarians + vegans vs. omnivores -0.048 -0.080, -0.016 <0.05 
Vegetarian vs. omnivores -0.035 -0.093, 0.022 NS4 
Vegans vs. omnivores -0.059 -0.106, -0.012 <0.05 




Table 3.  Dose-response meta-analyses examining the relative risk (RR) of cardiometabolic 1303 
diseases in relation to consumption of dairy foods (Adapted from data in Soedamah-Muthu 1304 
and de Goede, 2018). 1305 
Disease 
outcome 
Dairy food1  RR (95% CI2) P 
Diabetes 
mellitus 
Total dairy 0.97 (0.95-1.00) NS 
 Low fat dairy 0.96 (0.92-1.00) NS 
 Yogurt 0.94 (0.91-0.97) <0.05 
CHD3 Total dairy 1.00 (0.98-1.03) NS 
 Milk  1.01 (0.97-1.04) NS 
Stroke Total dairy  0.98 (0.96-1.01) NS 
 Low fat dairy 0.97 (0.95-0.99) <0.05 
 Full fat dairy 0.96 (0.93-0.99) <0.05 
 Milk 0.92 (0.88-0.97) <0.05 




Table 4. Changes in blood lipids from baseline to end of 6 weeks intervention when 40 g/d of 1307 
dairy fat were provided in 3 types of dairy products (Adapted from data in Feeney et al., 2018). 1308 
 Treatment  
Blood lipid (mmol/L) T11 T2 T3 P2 
Total cholesterol -0.52 -0.37 -0.15 0.033 
HDL-cholesterol 0 -0.07 +0.05 0.284 
LDL-cholesterol -0.45 -0.27 -0.14 0.016 
Triacylglycerols -0.15 -0.05 -0.12 0.386 
1T1, 120g Cheddar cheese, T2, 120g low fat Cheddar cheese + 21g butter, T3, 49g butter + 30g calcium caseinate 1309 
+ 500mg calcium (as CaCO3) 1310 
2for differences between treatments, for controlling factors included in model see original paper 1311 
